ID   FYN_RAT                 Reviewed;         537 AA.
AC   Q62844;
DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 194.
DE   RecName: Full=Tyrosine-protein kinase Fyn;
DE            EC=2.7.10.2;
DE   AltName: Full=Proto-oncogene c-Fyn;
DE   AltName: Full=p59-Fyn;
GN   Name=Fyn {ECO:0000312|RGD:2641};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000312|EMBL:AAA82942.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=SHRSP {ECO:0000312|EMBL:AAA82942.1};
RC   TISSUE=Brain {ECO:0000312|EMBL:AAA82942.1};
RA   Nemoto K., Sekimoto M., Kageyama H., Fukamachi K., Nemoto F., Ueyama T.,
RA   Senba E., Tomita I.;
RT   "Expression of three type mRNAs encoding rat FYN by alternative splicing
RT   within 5' untranslated region.";
RL   Submitted (SEP-1995) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000312|PIR:PT0199}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2062320; DOI=10.1016/0161-5890(91)90153-b;
RA   Yue C.C.;
RT   "Novel putative protein kinase clones from a rat large granular lymphocyte
RT   tumor cell line.";
RL   Mol. Immunol. 28:399-408(1991).
RN   [3] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE, AND MUTAGENESIS OF
RP   LYS-299.
RX   PubMed=10366594; DOI=10.1083/jcb.145.6.1209;
RA   Osterhout D.J., Wolven A., Wolf R.M., Resh M.D., Chao M.V.;
RT   "Morphological differentiation of oligodendrocytes requires activation of
RT   Fyn tyrosine kinase.";
RL   J. Cell Biol. 145:1209-1218(1999).
RN   [4]
RP   INTERACTION WITH KLHL2, AND TISSUE SPECIFICITY.
RX   PubMed=15715669; DOI=10.1111/j.1471-4159.2004.02946.x;
RA   Jiang S., Avraham H.K., Park S.Y., Kim T.A., Bu X., Seng S., Avraham S.;
RT   "Process elongation of oligodendrocytes is promoted by the Kelch-related
RT   actin-binding protein Mayven.";
RL   J. Neurochem. 92:1191-1203(2005).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-531, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Non-receptor tyrosine-protein kinase that plays a role in
CC       many biological processes including regulation of cell growth and
CC       survival, cell adhesion, integrin-mediated signaling, cytoskeletal
CC       remodeling, cell motility, immune response and axon guidance
CC       (PubMed:10366594). Inactive FYN is phosphorylated on its C-terminal
CC       tail within the catalytic domain (By similarity). Following activation
CC       by PKA, the protein subsequently associates with PTK2/FAK1, allowing
CC       PTK2/FAK1 phosphorylation, activation and targeting to focal adhesions
CC       (By similarity). Involved in the regulation of cell adhesion and
CC       motility through phosphorylation of CTNNB1 (beta-catenin) and CTNND1
CC       (delta-catenin) (By similarity). Regulates cytoskeletal remodeling by
CC       phosphorylating several proteins including the actin regulator WAS and
CC       the microtubule-associated proteins MAP2 and MAPT (By similarity).
CC       Promotes cell survival by phosphorylating AGAP2/PIKE-A and preventing
CC       its apoptotic cleavage (By similarity). Participates in signal
CC       transduction pathways that regulate the integrity of the glomerular
CC       slit diaphragm (an essential part of the glomerular filter of the
CC       kidney) by phosphorylating several slit diaphragm components including
CC       NPHS1, KIRREL1 and TRPC6 (By similarity). Plays a role in neural
CC       processes by phosphorylating DPYSL2, a multifunctional adapter protein
CC       within the central nervous system, ARHGAP32, a regulator for Rho family
CC       GTPases implicated in various neural functions, and SNCA, a small pre-
CC       synaptic protein (By similarity). Involved in reelin signaling by
CC       mediating phosphorylation of DAB1 following reelin (RELN)-binding to
CC       its receptor (By similarity). Participates in the downstream signaling
CC       pathways that lead to T-cell differentiation and proliferation
CC       following T-cell receptor (TCR) stimulation (By similarity).
CC       Phosphorylates PTK2B/PYK2 in response to T-cell receptor activation (By
CC       similarity). Also participates in negative feedback regulation of TCR
CC       signaling through phosphorylation of PAG1, thereby promoting
CC       interaction between PAG1 and CSK and recruitment of CSK to lipid rafts
CC       (By similarity). CSK maintains LCK and FYN in an inactive form (By
CC       similarity). Promotes CD28-induced phosphorylation of VAV1 (By
CC       similarity). In mast cells, phosphorylates CLNK after activation of
CC       immunoglobulin epsilon receptor signaling (By similarity).
CC       {ECO:0000250|UniProtKB:P06241, ECO:0000250|UniProtKB:P39688,
CC       ECO:0000269|PubMed:10366594}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028,
CC         ECO:0000269|PubMed:10366594};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:10366594};
CC   -!- ACTIVITY REGULATION: Inhibited by phosphorylation of Tyr-531 by
CC       leukocyte common antigen and activated by dephosphorylation of this
CC       site. {ECO:0000250}.
CC   -!- SUBUNIT: Interacts (via its SH3 domain) with PIK3R1 and PRMT8.
CC       Interacts with FYB1, PAG1, and SH2D1A. Interacts with CD79A (tyrosine-
CC       phosphorylated form); the interaction increases FYN activity. Interacts
CC       (via SH2 domain) with CSF1R (tyrosine phosphorylated) (By similarity).
CC       Interacts with TOM1L1 (phosphorylated form). Interacts with KDR
CC       (tyrosine phosphorylated). Interacts (via SH3 domain) with KLHL2 (via
CC       N-terminus) (PubMed:15715669). Interacts with SH2D1A and SLAMF1.
CC       Interacts with ITCH; the interaction phosphorylates ITCH and negatively
CC       regulates its activity. Interacts with FASLG. Interacts with RUNX3.
CC       Interacts with KIT. Interacts with EPHA8; possible downstream effector
CC       of EPHA8 in regulation of cell adhesion. Interacts with PTK2/FAK1; this
CC       interaction leads to PTK2/FAK1 phosphorylation and activation.
CC       Interacts with CAV1; this interaction couples integrins to the Ras-ERK
CC       pathway. Interacts with UNC119. Interacts (via SH2 domain) with PTPRH
CC       (phosphorylated form) (By similarity). Interacts with PTPRO
CC       (phosphorylated form) (By similarity). Interacts with PTPRB
CC       (phosphorylated form) (By similarity). Interacts with FYB2 (By
CC       similarity). Interacts with DSCAM (By similarity). Interacts with SKAP1
CC       and FYB1; this interaction promotes the phosphorylation of CLNK (By
CC       similarity). Interacts with NEDD9; in the presence of PTK2 (By
CC       similarity). {ECO:0000250|UniProtKB:P06241,
CC       ECO:0000250|UniProtKB:P39688, ECO:0000269|PubMed:15715669}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P06241}. Nucleus
CC       {ECO:0000250|UniProtKB:P06241}. Cell membrane
CC       {ECO:0000250|UniProtKB:P06241}. Perikaryon
CC       {ECO:0000269|PubMed:10366594}. Note=Present and active in lipid rafts
CC       (By similarity). Palmitoylation is crucial for proper trafficking (By
CC       similarity). {ECO:0000250|UniProtKB:P06241}.
CC   -!- TISSUE SPECIFICITY: Detected in spinal cord oligodendrocytes (at
CC       protein level). {ECO:0000269|PubMed:15715669}.
CC   -!- DEVELOPMENTAL STAGE: Up-regulated during oligodendrocyte
CC       differentiation. {ECO:0000269|PubMed:10366594}.
CC   -!- PTM: Autophosphorylated at Tyr-420 (By similarity). Phosphorylation on
CC       the C-terminal tail at Tyr-531 by CSK maintains the enzyme in an
CC       inactive state. PTPRC/CD45 dephosphorylates Tyr-531 leading to
CC       activation. Dephosphorylation at Tyr-420 by PTPN2 negatively regulates
CC       T-cell receptor signaling (By similarity). Phosphorylated at tyrosine
CC       residues, which can be enhanced by NTN1 (By similarity).
CC       {ECO:0000250|UniProtKB:P06241, ECO:0000250|UniProtKB:P39688}.
CC   -!- PTM: Palmitoylated. Palmitoylation at Cys-3 and Cys-6, probably by
CC       ZDHHC21, regulates subcellular location.
CC       {ECO:0000250|UniProtKB:P39688}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. SRC subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U35365; AAA82942.1; -; mRNA.
DR   PIR; PT0199; PT0199.
DR   RefSeq; NP_036887.1; NM_012755.1.
DR   AlphaFoldDB; Q62844; -.
DR   SMR; Q62844; -.
DR   BioGRID; 247215; 6.
DR   CORUM; Q62844; -.
DR   IntAct; Q62844; 4.
DR   MINT; Q62844; -.
DR   STRING; 10116.ENSRNOP00000000733; -.
DR   iPTMnet; Q62844; -.
DR   PhosphoSitePlus; Q62844; -.
DR   SwissPalm; Q62844; -.
DR   jPOST; Q62844; -.
DR   PaxDb; 10116-ENSRNOP00000000733; -.
DR   Ensembl; ENSRNOT00000000733.5; ENSRNOP00000000733.1; ENSRNOG00000000596.7.
DR   Ensembl; ENSRNOT00055001252; ENSRNOP00055001005; ENSRNOG00055000725.
DR   Ensembl; ENSRNOT00060012148; ENSRNOP00060009164; ENSRNOG00060007389.
DR   Ensembl; ENSRNOT00065014115; ENSRNOP00065010550; ENSRNOG00065008840.
DR   GeneID; 25150; -.
DR   KEGG; rno:25150; -.
DR   UCSC; RGD:2641; rat.
DR   AGR; RGD:2641; -.
DR   CTD; 2534; -.
DR   RGD; 2641; Fyn.
DR   eggNOG; KOG0197; Eukaryota.
DR   GeneTree; ENSGT00940000155462; -.
DR   InParanoid; Q62844; -.
DR   OrthoDB; 1614410at2759; -.
DR   PhylomeDB; Q62844; -.
DR   TreeFam; TF351634; -.
DR   Reactome; R-RNO-114604; GPVI-mediated activation cascade.
DR   Reactome; R-RNO-1227986; Signaling by ERBB2.
DR   Reactome; R-RNO-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-RNO-1433557; Signaling by SCF-KIT.
DR   Reactome; R-RNO-1433559; Regulation of KIT signaling.
DR   Reactome; R-RNO-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-RNO-2029481; FCGR activation.
DR   Reactome; R-RNO-210990; PECAM1 interactions.
DR   Reactome; R-RNO-2424491; DAP12 signaling.
DR   Reactome; R-RNO-373753; Nephrin family interactions.
DR   Reactome; R-RNO-375165; NCAM signaling for neurite out-growth.
DR   Reactome; R-RNO-389356; CD28 co-stimulation.
DR   Reactome; R-RNO-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-RNO-389359; CD28 dependent Vav1 pathway.
DR   Reactome; R-RNO-389513; CTLA4 inhibitory signaling.
DR   Reactome; R-RNO-3928662; EPHB-mediated forward signaling.
DR   Reactome; R-RNO-3928663; EPHA-mediated growth cone collapse.
DR   Reactome; R-RNO-3928664; Ephrin signaling.
DR   Reactome; R-RNO-3928665; EPH-ephrin mediated repulsion of cells.
DR   Reactome; R-RNO-399954; Sema3A PAK dependent Axon repulsion.
DR   Reactome; R-RNO-399955; SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion.
DR   Reactome; R-RNO-399956; CRMPs in Sema3A signaling.
DR   Reactome; R-RNO-418885; DCC mediated attractive signaling.
DR   Reactome; R-RNO-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-RNO-5621480; Dectin-2 family.
DR   Reactome; R-RNO-5621575; CD209 (DC-SIGN) signaling.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-RNO-75892; Platelet Adhesion to exposed collagen.
DR   Reactome; R-RNO-8866376; Reelin signalling pathway.
DR   Reactome; R-RNO-9032759; NTRK2 activates RAC1.
DR   Reactome; R-RNO-912631; Regulation of signaling by CBL.
DR   PRO; PR:Q62844; -.
DR   Proteomes; UP000002494; Chromosome 20.
DR   Bgee; ENSRNOG00000000596; Expressed in thymus and 20 other cell types or tissues.
DR   ExpressionAtlas; Q62844; baseline and differential.
DR   GO; GO:0005884; C:actin filament; ISO:RGD.
DR   GO; GO:0044297; C:cell body; ISO:RGD.
DR   GO; GO:0071944; C:cell periphery; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030425; C:dendrite; IDA:ARUK-UCL.
DR   GO; GO:0005768; C:endosome; ISO:RGD.
DR   GO; GO:0097386; C:glial cell projection; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0045121; C:membrane raft; ISO:RGD.
DR   GO; GO:0005739; C:mitochondrion; IDA:ARUK-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:ARUK-UCL.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0097038; C:perinuclear endoplasmic reticulum; IDA:ARUK-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:ARUK-UCL.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0014069; C:postsynaptic density; IDA:ARUK-UCL.
DR   GO; GO:0099092; C:postsynaptic density, intracellular component; IDA:SynGO.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISO:RGD.
DR   GO; GO:0043014; F:alpha-tubulin binding; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042609; F:CD4 receptor binding; IPI:RGD.
DR   GO; GO:0042610; F:CD8 receptor binding; IPI:RGD.
DR   GO; GO:0097718; F:disordered domain specific binding; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; IPI:RGD.
DR   GO; GO:0046875; F:ephrin receptor binding; ISO:RGD.
DR   GO; GO:0001664; F:G protein-coupled receptor binding; ISO:RGD.
DR   GO; GO:0070851; F:growth factor receptor binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; ISO:RGD.
DR   GO; GO:0051428; F:peptide hormone receptor binding; IPI:RGD.
DR   GO; GO:0043548; F:phosphatidylinositol 3-kinase binding; IDA:RGD.
DR   GO; GO:0016004; F:phospholipase activator activity; ISO:RGD.
DR   GO; GO:0043274; F:phospholipase binding; ISO:RGD.
DR   GO; GO:0004672; F:protein kinase activity; IDA:RGD.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IDA:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0097110; F:scaffold protein binding; ISO:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:RGD.
DR   GO; GO:0042608; F:T cell receptor binding; IDA:RGD.
DR   GO; GO:0048156; F:tau protein binding; ISO:RGD.
DR   GO; GO:0044325; F:transmembrane transporter binding; ISO:RGD.
DR   GO; GO:0015631; F:tubulin binding; ISO:RGD.
DR   GO; GO:0031802; F:type 5 metabotropic glutamate receptor binding; IPI:ARUK-UCL.
DR   GO; GO:0050798; P:activated T cell proliferation; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0007169; P:cell surface receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; ISO:RGD.
DR   GO; GO:1904646; P:cellular response to amyloid-beta; ISO:RGD.
DR   GO; GO:1905430; P:cellular response to glycine; IMP:ARUK-UCL.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IEP:RGD.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IDA:ARUK-UCL.
DR   GO; GO:1905232; P:cellular response to L-glutamate; IMP:ARUK-UCL.
DR   GO; GO:0071375; P:cellular response to peptide hormone stimulus; IEP:RGD.
DR   GO; GO:0036120; P:cellular response to platelet-derived growth factor stimulus; ISO:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; ISO:RGD.
DR   GO; GO:0048813; P:dendrite morphogenesis; ISO:RGD.
DR   GO; GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; ISO:RGD.
DR   GO; GO:0030900; P:forebrain development; ISO:RGD.
DR   GO; GO:0007216; P:G protein-coupled glutamate receptor signaling pathway; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0003015; P:heart process; ISO:RGD.
DR   GO; GO:0045087; P:innate immune response; IBA:GO_Central.
DR   GO; GO:0035556; P:intracellular signal transduction; ISO:RGD.
DR   GO; GO:0035235; P:ionotropic glutamate receptor signaling pathway; TAS:RGD.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:1902951; P:negative regulation of dendritic spine maintenance; ISO:RGD.
DR   GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IMP:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0010730; P:negative regulation of hydrogen peroxide biosynthetic process; IMP:ARUK-UCL.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IMP:UniProtKB.
DR   GO; GO:1902176; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; IMP:ARUK-UCL.
DR   GO; GO:0042177; P:negative regulation of protein catabolic process; ISO:RGD.
DR   GO; GO:0031397; P:negative regulation of protein ubiquitination; ISO:RGD.
DR   GO; GO:0001764; P:neuron migration; ISO:RGD.
DR   GO; GO:0031175; P:neuron projection development; ISO:RGD.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IMP:ARUK-UCL.
DR   GO; GO:2001056; P:positive regulation of cysteine-type endopeptidase activity; IMP:ARUK-UCL.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; ISO:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IMP:UniProtKB.
DR   GO; GO:1900182; P:positive regulation of protein localization to nucleus; ISO:RGD.
DR   GO; GO:0090314; P:positive regulation of protein targeting to membrane; ISO:RGD.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; ISO:RGD.
DR   GO; GO:0030163; P:protein catabolic process; ISO:RGD.
DR   GO; GO:0016567; P:protein ubiquitination; ISO:RGD.
DR   GO; GO:0038026; P:reelin-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:1905664; P:regulation of calcium ion import across plasma membrane; ISO:RGD.
DR   GO; GO:0008360; P:regulation of cell shape; ISO:RGD.
DR   GO; GO:1900449; P:regulation of glutamate receptor signaling pathway; ISO:RGD.
DR   GO; GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:1904645; P:response to amyloid-beta; ISO:RGD.
DR   GO; GO:0045471; P:response to ethanol; ISO:RGD.
DR   GO; GO:0000304; P:response to singlet oxygen; IDA:ARUK-UCL.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; ISO:RGD.
DR   CDD; cd05070; PTKc_Fyn; 1.
DR   CDD; cd10418; SH2_Src_Fyn_isoform_a_like; 1.
DR   CDD; cd12006; SH3_Fyn_Yrk; 1.
DR   Gene3D; 3.30.505.10; SH2 domain; 1.
DR   Gene3D; 2.30.30.40; SH3 Domains; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR047924; Fyn/Yrk_SH2.
DR   InterPro; IPR035750; Fyn/Yrk_SH3.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR050198; Non-receptor_tyrosine_kinases.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   PANTHER; PTHR24418; TYROSINE-PROTEIN KINASE; 1.
DR   PANTHER; PTHR24418:SF44; TYROSINE-PROTEIN KINASE FYN; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   SUPFAM; SSF55550; SH2 domain; 1.
DR   SUPFAM; SSF50044; SH3-domain; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Cytoplasm; Developmental protein; Kinase;
KW   Lipoprotein; Manganese; Membrane; Metal-binding; Myristate;
KW   Nucleotide-binding; Nucleus; Palmitate; Phosphoprotein; Reference proteome;
KW   SH2 domain; SH3 domain; Transferase; Tyrosine-protein kinase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P06241"
FT   CHAIN           2..537
FT                   /note="Tyrosine-protein kinase Fyn"
FT                   /id="PRO_0000282948"
FT   DOMAIN          82..143
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          149..246
FT                   /note="SH2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          271..524
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          14..35
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        18..35
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        390
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P28523,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-
FT                   ProRule:PRU10028"
FT   BINDING         277..285
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P28523,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         299
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000269|PubMed:10366594"
FT   MOD_RES         21
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06241"
FT   MOD_RES         26
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06241"
FT   MOD_RES         185
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P39688"
FT   MOD_RES         420
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P39688"
FT   MOD_RES         531
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000250|UniProtKB:P39688"
FT   LIPID           3
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P39688"
FT   LIPID           6
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P39688"
FT   MUTAGEN         299
FT                   /note="K->M: Loss of kinase activity and reduction in
FT                   oligodendrocyte process extension and myelin membrane
FT                   formation."
FT                   /evidence="ECO:0000269|PubMed:10366594"
SQ   SEQUENCE   537 AA;  60702 MW;  11AE4420919DBF1C CRC64;
     MGCVQCKDKE AAKLTEERDG SLNQSSGYRY GTDPTPQHYP SFGVTSIPNY NNFHAAGGQG
     LTVFGGVNSS SHTGTLRTRG GTGVTLFVAL YDYEARTEDD LSFHKGEKFQ ILNSSEGDWW
     EARSLTTGET GYIPSNYVAP VDSIQAEEWY FGKLGRKDAE RQLLSFGNPR GTFLIRESET
     TKGAYSLSIR DWDDMKGDHV KHYKIRKLDN GGYYITTRAQ FETLQQLVQH YSERAAGLCC
     RLVVPCHKGM PRLTDLSVKT KDVWEIPRES LQLIKRLGNG QFGEVWMGTW NGNTKVAIKT
     LKPGTMSPES FLEEAQIMKK LKHDKLVQLY AVVSEEPIYI VTEYMNKGSL LDFLKDGEGR
     ALKLPNLVDM AAQVAAGMAY IERMNYIHRD LRSANILVGN GLICKIADFG LARLIEDNEY
     TARQGAKFPI KWTAPEAALY GRFTIKSDVW SFGILLTELV TKGRVPYPGM NNREVLEQVE
     RGYRMPCPQD CPISLHELMI HCWKKDPEER PTFEYLQGFL EDYFTATEPQ YQPGENL
//
